NIH-funded research R01 grant

Epigenetic aging and racial disparities in early-onset prostate cancer

Official title: Epigenetic aging as a driver of racial disparities in early onset prostate cancer

Funded at Roswell Park Cancer Institute Corp · NIH-11397784 · Data updated 2026-11-12

This grant studies whether biological aging markers differ in African American men with prostate cancer and if that helps explain why they face higher risk and earlier onset.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRoswell Park Cancer Institute Corp
NIH-funded
Lab location1 site (Buffalo, United States)
Project startSeptember 20, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$688,656
NIH project number5R01CA298785-03
Project IDNIH-11397784 on NIH RePORTER

Who could benefit from this research

Could help

African American men diagnosed with prostate cancer, and age-matched European American men for comparison.

Less likely to help

People without prostate cancer or those not represented in the study populations may not benefit directly.

What this research studies

The project looks at how epigenetic aging, especially ribosomal DNA methylation, relates to early-onset prostate cancer in African American men. Researchers will compare rDNA methylation age at diagnosis between African American and European American patients and examine how race and age interact with cancer biology. By using patient tissue samples and aging markers, the study aims to identify molecular clues that could explain disparities. The findings could point toward personalized approaches to risk assessment and prevention in high-risk groups.

Why it matters

Potential benefit: If successful, the work could lead to better risk stratification and targeted prevention or treatment strategies for African American men at risk of early-onset prostate cancer.

How similar studies have gone: Prior research suggests epigenetic aging markers are linked to cancer biology, but this specific racial disparity focus is relatively novel and exploratory.

Where this research is happening

  • Roswell Park Cancer Institute Corp
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Woloszynska-Read, Anna — Roswell Park Cancer Institute Corp
  • Study coordinator: Woloszynska-Read, Anna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.